Release Date: 21/11/18 09:49 Summary: Notice to set Arena Investors statutory demand aside Price Sensitive: Yes Download Document 402.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%